|
DCI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.14910328316864E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77670000933716E-09 |
| Normal-vs-Stage2 |
1.339000E-01 |
| Normal-vs-Stage3 |
2.070000E-02 |
| Normal-vs-Stage4 |
9.391700E-02 |
| Stage1-vs-Stage2 |
1.952040E-02 |
| Stage1-vs-Stage3 |
1.135560E-01 |
| Stage1-vs-Stage4 |
7.797800E-01 |
| Stage2-vs-Stage3 |
5.146200E-01 |
| Stage2-vs-Stage4 |
2.782400E-01 |
| Stage3-vs-Stage4 |
5.441800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.72760053327193E-10 |
| Normal-vs-AfricanAmerican |
2.000100E-04 |
| Normal-vs-Asian |
6.711000E-01 |
| Caucasian-vs-AfricanAmerican |
9.676200E-01 |
| Caucasian-vs-Asian |
3.338400E-01 |
| AfricanAmerican-vs-Asian |
3.557800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.14348588562552E-13 |
| Normal-vs-Female |
6.391900E-02 |
| Male-vs-Female |
1.639100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.645600E-02 |
| Normal-vs-Extreme_Weight |
5.71980000030337E-08 |
| Normal-vs-Obese |
3.411200E-04 |
| Normal-vs-Extreme_Obese |
1.822570E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.644020E-02 |
| Normal_Weight-vs-Obese |
2.680600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.164000E-02 |
| Extreme_Weight-vs-Obese |
1.252650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.927400E-01 |
| Obese-vs-Extreme_Obese |
2.328800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.376820E-01 |
| Normal-vs-Age(41-60Yrs) |
1.67905999999274E-05 |
| Normal-vs-Age(61-80Yrs) |
3.85209975028999E-10 |
| Normal-vs-Age(81-100Yrs) |
7.784200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.722000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.782600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.634560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.197020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.136010E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.05599999994577E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62925228863742E-12 |
| Normal-VS-Type2 PRCC |
2.152400E-02 |
| Normal-VS-KIRP CIMP |
2.984600E-01 |
| Normal-VS-Unclassified PRCC |
2.613500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.83960000016614E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.407630E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.037600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.738200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.462600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.581990E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.177000E-03 |
| Normal-vs-N1 |
5.007000E-01 |
| Normal-vs-N2 |
7.458300E-02 |
| N0-vs-N1 |
2.113800E-02 |
| N0-vs-N2 |
9.848800E-04 |
| N1-vs-N2 |
2.774800E-01 |
|
|
